633.0000 21.45 (3.51%)
NSE Oct 26, 2026 13:15 PM
Volume: 174.9K
 

633.00
3.51%
Axis Direct
We expect the whole API industry to continue facing challenges due to a fall in realization as well as an increase in cost pressure. We foresee the situation to continue for the next 2-3 quarters and therefore recommend a HOLD rating on the stock with the target price of Rs 1,300/share.
Solara Active Pharma has gained 28.67% in the last 3 Months
More from Solara Active Pharma Sciences Ltd.
Recommended